Verona Pharma plc (VRNA) Financials

VRNA Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 356.7 million 35.3 million
2023-06-30 383.7 million 38.9 million
2023-03-31 400.4 million 57.5 million
2022-12-31 314.0 million 35.1 million

VRNA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -15.5 million 6.2 million
2023-06-30 -26.9 million 6.4 million
2023-03-31 -7.2 million 5.3 million
2022-12-31 -9.4 million 5.5 million

VRNA Net Income

No data available :(

VRNA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 313.9 million - 483001
2023-06-30 341.8 million - 725911
2023-03-31 361.1 million - 885893
2022-12-31 275.7 million - 1.1 million

VRNA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 778.5 million
2023-06-30 1.0 billion
2023-03-31 962.5 million
2022-12-31 715.8 million

VRNA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 3.6 million 16.3 million -
2023-06-30 - 3.1 million 15.7 million -
2023-03-31 - 15.6 million 11.9 million -
2022-12-31 - 8.3 million 10.1 million -

VRNA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - -
2023-06-30 - -
2023-03-31 - -
2022-12-31 554245 418709

VRNA

Price: $15.69

52 week price:
11.83
23.81

Earnings Per Share: -0.72 USD

P/E Ratio: -30.25

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 555000

Ebitda: -10.7 million

Market Capitalization: 1.3 billion

Links: